Ellomay Capital Balance Sheet Health
Financial Health criteria checks 1/6
Ellomay Capital has a total shareholder equity of €82.7M and total debt of €379.7M, which brings its debt-to-equity ratio to 459.2%. Its total assets and total liabilities are €574.3M and €491.7M respectively. Ellomay Capital's EBIT is €5.3M making its interest coverage ratio 0.3. It has cash and short-term investments of €61.7M.
Key information
459.2%
Debt to equity ratio
€379.69m
Debt
| Interest coverage ratio | 0.3x |
| Cash | €61.71m |
| Equity | €82.69m |
| Total liabilities | €491.65m |
| Total assets | €574.34m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: NUR's short term assets (€78.5M) do not cover its short term liabilities (€103.9M).
Long Term Liabilities: NUR's short term assets (€78.5M) do not cover its long term liabilities (€387.7M).
Debt to Equity History and Analysis
Debt Level: NUR's net debt to equity ratio (384.6%) is considered high.
Reducing Debt: NUR's debt to equity ratio has increased from 115.9% to 459.2% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: NUR has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: NUR has less than a year of cash runway if free cash flow continues to reduce at historical rates of 40.2% each year